Elevated PRMT1 expression is found in several cancer types and is associated with poor prognosis and chemoinsensitivity (Altan et al., 2016; Musiani et al., 2020) and pharmacological PRMT inhibitors have recently gained interest as drug candidates for cancer treatment (Guccione and Richard, 2019; Jarrold and Davies, 2019). The gene discussed is PRMT1; the disease is cancer.